Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Traphaco

Market Cap 3,27500Cr 12Cr 11Cr 9.93Cr 9.29Cr 17Cr 1.19TCr 18Cr 117.21Cr 46Cr 577.03Cr 47Cr 46Cr 2TCr P/E Ratio 2024
15.7x
P/E Ratio 2025 14.3x
Enterprise Value 2,70500Cr 10Cr 8.9Cr 8.2Cr 7.68Cr 14Cr 979.36Cr 15Cr 97Cr 38Cr 476.69Cr 39Cr 38Cr 1.65TCr EV / Sales 2024
1.16x
EV / Sales 2025 0.96x
Free-Float
55.44%
Yield 2024
5.1%
Yield 2025 -
29/04 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
23/02 Traphaco Joint Stock Company Receives Large Enterprise Tax Department Decision on Tax Inspection and Administrative Penalties for Fiscal Years 2023 and 2024 CI
30/01 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
26/12 Traphaco Joint Stock Company Announces First Cash Dividend Payment in 2025, Payable on January 28, 2026 CI
19/11 Traphaco Joint Stock Company Announces Change in Business Registration Certificate Issued by Hanoi Department of Finance CI
10/11 Traphaco Joint Stock Company Announces Chief Executive Officer Changes, Effective November 10, 2025 CI
06/11 Traphaco Joint Stock Company Announces Resignation of Ms. Nguyen Thi Giang as Member of the Board of Supervisors CI
29/25/29 Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
10/25/10 Traphaco Joint Stock Company Announces Dissolution of Branches CI
29/25/29 Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
30/25/30 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
03/25/03 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
16/24/16 Traphaco Joint Stock Company Approves First Interim Dividend for 2024, Payable on January 24, 2025 CI
1 day-1.13%
1 week-1.25%
Current month-1.25%
1 month-1.25%
3 months+12.22%
6 months+16.86%
Current year+5.33%
1 week 78,100
Extreme 78100
80,800
1 month 78,100
Extreme 78100
81,000
Current year 65,000
Extreme 65000
81,000
1 year 63,000
Extreme 63000
81,000
3 years 63,000
Extreme 63000
95,900
5 years 63,000
Extreme 63000
1,05,000
10 years 43,100
Extreme 43100
1,42,000
Manager TitleAgeSince
Chief Executive Officer 61 17/09/2012
Corporate Secretary - 30/03/2018
Comptroller/Controller/Auditor 44 01/01/1994
Director TitleAgeSince
Chairman 70 18/10/2010
Director/Board Member 61 01/01/1994
Director/Board Member 48 30/03/2016
Date Insider Type Main position Quantity % Market Cap.
15/25/15Buy 33,264 0.0802%
05/23/05Sell

Executive/Senior Manager

7,200 0.0174%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-1.25%+8.22%-12.90% 12Cr
-2.41%+0.14%+39.53%+154.43% 1,01000Cr
+1.07%+3.48%+53.75%+50.64% 58TCr
+1.32%+0.22%+18.35%+65.35% 40TCr
+0.77%0.00%+19.99%+16.80% 33TCr
-1.42%-1.44%+45.50%+8.37% 29TCr
-0.85%-2.86%+22.05%+13.80% 28TCr
+0.44%+3.48%+24.48%+34.39% 28TCr
+1.66%+1.20%-44.67%-47.49% 20TCr
+0.32%+1.61%+19.48%+63.42% 19TCr
Average -0.37%+0.78%+20.67%+34.68% 35.67TCr
Weighted average by Cap. -0.80%+1.00%+29.84%+66.16%

Financials

2024 2025
Net sales 2,34700Cr 8.94Cr 7.72Cr 7.12Cr 6.66Cr 12Cr 849.76Cr 13Cr 84Cr 33Cr 413.61Cr 34Cr 33Cr 1.43TCr 2,65700Cr 10Cr 8.74Cr 8.06Cr 7.54Cr 14Cr 961.99Cr 14Cr 95Cr 37Cr 468.23Cr 38Cr 37Cr 1.62TCr
Net income 24TCr 91.04L 78.63L 72.46L 67.82L 1.27Cr 87Cr 1.29Cr 8.56Cr 3.34Cr 42Cr 3.42Cr 3.34Cr 145.83Cr 25TCr 95.09L 82.13L 75.68L 70.84L 1.33Cr 90Cr 1.35Cr 8.94Cr 3.48Cr 44Cr 3.57Cr 3.49Cr 152.32Cr
Net Debt -54TCr -2.06Cr -1.78Cr -1.64Cr -1.53Cr -2.87Cr -195.66Cr -2.92Cr -19Cr -7.54Cr -95Cr -7.73Cr -7.56Cr -329.75Cr -57TCr -2.17Cr -1.87Cr -1.73Cr -1.62Cr -3.03Cr -206.13Cr -3.07Cr -20Cr -7.95Cr -100.33Cr -8.14Cr -7.97Cr -347.4Cr
Logo Traphaco
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Employees
1,546
Date Price Change Volume
12/26/12 79,000.00 -1.13% 1,115
11/26/11 79,900.00 -0.12% 2,734
10/26/10 80,000.00 +0.38% 105
09/26/09 79,700.00 -0.25% 2,738
08/26/08 79,900.00 -0.12% 7,829

Net sales - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!